FibroBiologics locks up wound-healing patent
New US patent covers fibroblast-based treatment for wounds that won’t close – increasingly common, and risky, with age. Houston-based FibroBiologics got some good news from the patent office this month. The kind that matters a lot if you’re a company trying to build a business around cells tha
<p>New US patent covers fibroblast-based treatment for wounds that won’t close – increasingly common, and risky, with age. Houston-based FibroBiologics got some good news from the patent office this month. The kind that matters a lot if you’re a company trying to build a business around cells tha</p>